| Identification | |
|---|---|
| Name | 2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline |
| Accession Number | DB08386 |
| Type | small molecule |
| Description | Not Available |
| Structure |
|
| Categories (*) | |
| Molecular Weight | 378.4259 |
| Groups | experimental |
| Monoisotopic Weight | 378.148061218 |
| Pharmacology | |
| Indication | Not Available |
| Mechanism of action | Not Available |
| Absorption | Not Available |
| Protein binding | Not Available |
| Biotransformation | Not Available |
| Route of elimination | Not Available |
| Toxicity | Not Available |
| Affected organisms | Not Available |
| Interactions | |
| Drug Interactions | Not Available |
| Food Interactions | Not Available |
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | |
|---|---|
| Name | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A |
| Gene Name | PDE10A |
| Pharmacological action | unknown |
| Actions | Not Available |
| References |
|
| DTHybrid score | Not Available |
| Id | Partner name | Gene Name | Score |
|---|---|---|---|
| 541 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | PDE4B | 0.0564 |
| 1787 | Nuclear factor NF-kappa-B p105 subunit | NFKB1 | 0.0422 |
| 1971 | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | PDE4A | 0.0416 |
| 3806 | cGMP-dependent 3',5'-cyclic phosphodiesterase | PDE2A | 0.0402 |
| 7 | Nitric oxide synthase, inducible | NOS2 | 0.0288 |
| 485 | cGMP-inhibited 3',5'-cyclic phosphodiesterase A | PDE3A | 0.0249 |
| 20 | Prostaglandin G/H synthase 1 | PTGS1 | 0.0198 |
| 204 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE5A | 0.0188 |
| 3957 | Adenosine deaminase | ADA | 0.0176 |
| 6136 | Multidrug resistance-associated protein 5 | ABCC5 | 0.0152 |
| 2164 | Multidrug resistance-associated protein 4 | ABCC4 | 0.0128 |
| 4512 | Cytochrome P450 3A4 | CYP3A4 | 0.0109 |
| 1588 | Multidrug resistance protein 1 | ABCB1 | 0.0089 |